Health
FDA conditionally approves first oral treatment for dogs with lymphoma – News-Medical.Net
Today, the U.S. Food and Drug Administration conditionally approved Laverdia-CA1 (verdinexor tablets) to treat dogs with lymphoma, a type of cancer of the lymph…
Today, the U.S. Food and Drug Administration conditionally approved Laverdia-CA1 (verdinexor tablets) to treat dogs with lymphoma, a type of cancer of the lymph nodes and lymphatic system. Laverdia-CA1 works to prevent certain proteins from leaving the nucleus of cancer cells, thereby allowing these proteins to control the growth and prevent the spread of cancerous cells in dogs.
Laverdia-CA1 is the first conditionally approved oral treatment for dogs with lymphoma. Because Laverdia-CA1 is orally…
-
General24 hours agoPolice investigating after body found on road in Newborough, Gippsland
-
General14 hours agoMan dies in daylight shooting in Sydney’s north-west
-
Noosa News23 hours agoCouncil steps up staff protection after surge in abuse
-
Business16 hours agoOrd Minnett names 2 ASX 200 shares to buy